BLUEBIRD BIO INC's ticker is BLUE and the CUSIP is 09609G100. A total of 179 filers reported holding BLUEBIRD BIO INC in Q2 2016. The put-call ratio across all filers is 1.01 and the average weighting 0.2%.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $28,000 | -70.8% | 15,766 | +5.7% | 0.00% | – |
| Q4 2021 | $96,000 | -63.2% | 14,910 | +4.5% | 0.00% | -100.0% |
| Q3 2021 | $261,000 | -49.1% | 14,267 | -7.1% | 0.00% | 0.0% |
| Q2 2021 | $513,000 | -44.1% | 15,359 | -30.4% | 0.00% | -50.0% |
| Q1 2021 | $918,000 | -41.8% | 22,071 | -40.8% | 0.00% | -50.0% |
| Q4 2020 | $1,576,000 | -12.3% | 37,271 | +10.8% | 0.00% | -20.0% |
| Q3 2020 | $1,798,000 | +7.6% | 33,640 | +18.5% | 0.01% | 0.0% |
| Q2 2020 | $1,671,000 | +26.0% | 28,388 | -1.6% | 0.01% | 0.0% |
| Q1 2020 | $1,326,000 | -17.5% | 28,859 | +57.6% | 0.01% | 0.0% |
| Q4 2019 | $1,607,000 | +193.8% | 18,312 | +207.5% | 0.01% | +400.0% |
| Q3 2019 | $547,000 | -11.5% | 5,955 | +51.5% | 0.00% | -50.0% |
| Q1 2019 | $618,000 | +210.6% | 3,930 | +188.5% | 0.00% | +100.0% |
| Q4 2018 | $199,000 | 0.0% | 1,362 | 0.0% | 0.00% | 0.0% |
| Q3 2018 | $199,000 | -92.8% | 1,362 | -92.2% | 0.00% | -88.9% |
| Q2 2018 | $2,754,000 | +186.0% | 17,550 | +211.5% | 0.01% | +125.0% |
| Q1 2018 | $963,000 | -16.0% | 5,634 | -12.4% | 0.00% | 0.0% |
| Q4 2017 | $1,146,000 | +3083.3% | 6,432 | +2336.4% | 0.00% | – |
| Q3 2017 | $36,000 | -78.8% | 264 | -89.5% | 0.00% | -100.0% |
| Q3 2016 | $170,000 | +220.8% | 2,515 | +106.7% | 0.00% | – |
| Q2 2016 | $53,000 | -20.9% | 1,217 | -23.2% | 0.00% | – |
| Q1 2016 | $67,000 | -56.5% | 1,585 | -33.8% | 0.00% | -100.0% |
| Q4 2015 | $154,000 | +450.0% | 2,394 | +625.5% | 0.00% | – |
| Q3 2015 | $28,000 | -63.2% | 330 | -26.8% | 0.00% | -100.0% |
| Q2 2015 | $76,000 | -81.6% | 451 | -86.8% | 0.00% | -75.0% |
| Q1 2015 | $413,000 | -34.8% | 3,418 | -50.5% | 0.00% | -33.3% |
| Q4 2014 | $633,000 | – | 6,906 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TANG CAPITAL MANAGEMENT LLC | 4,282,827 | $13,019,794 | 1.84% |
| Birchview Capital, LP | 455,200 | $1,383,808 | 1.18% |
| PFM Health Sciences, LP | 6,040,934 | $18,364,439 | 0.86% |
| Lion Point Capital, LP | 531,256 | $1,615,018 | 0.72% |
| Endurant Capital Management LP | 251,785 | $765,426 | 0.69% |
| Bleichroeder LP | 900,000 | $2,736,000 | 0.67% |
| Connacht Asset Management LP | 31,634 | $96,167 | 0.57% |
| Granahan Investment Management | 5,137,778 | $15,618,845 | 0.56% |
| Frazier Life Sciences Management, L.P. | 1,709,907 | $5,198,117 | 0.34% |
| Contrarius Investment Management Ltd | 1,308,002 | $3,976 | 0.22% |